Arif Bilal 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Arif Bilal
Chief Tech Ops Officer
Transactions
- Tax Payment
Common Stock
2025-03-07$103.70/sh−508$52,680→ 33,274 total - Exercise/Conversion
Common Stock
2025-03-06+17,500→ 33,782 total - Tax Payment
Common Stock
2025-03-07$103.70/sh−8,527$884,250→ 24,747 total - Exercise/Conversion
Performance Stock Units
2025-03-06−17,500→ 0 total→ Common Stock (17,500 underlying)
Footnotes (3)
- [F1]Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU.
- [F2]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.
- [F3]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.